Dr. Reddy's signs licensing pact with Japan's Eisai for anticancer agent

Indian firm will acquire rights to develop and market investigational anticancer agent, E7777, in Europe, US.

from IBTimes.co.in : Science http://ift.tt/1UW5qdo